GHK-Cu is a safe, biological peptide therapy designed to optimize cellular repair, skin thickness, and hair density
In the Phase 2 dose-finding trial, men and women receiving cagrilintide 4.5 mg achieved mean weight loss of 10.8% over 26 weeks
Semaglutide comes in 3 brands: These all contain semaglutide as the active ingredient
This new medication shows more promise for weight management than other drugs that only impact GLP-1 alone
10.1111/dom.14908 Summary Keywords atrial fibrillation, atrial remodeling, epicardial adipose tissue, glucagon-like peptide-1 receptor agonist, therapeutic target Citation Liu L and Lu J (2026) Research on epicardial adipose tissue as a metabolic therapeutic target in AF: focus on GLP-1 receptor agonists
The molecular stress response